{"entity":{"type":"insider","cik":"0001983476","url":"/insider/0001983476","json_url":"/insider/0001983476.json","name":"Dambkowski Carl","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":62,"n_filings":30,"first":"2024-07-05","last":"2026-08-07","span_basis":"filed_date"},"name_variants":[{"name":"Dambkowski Carl","source":"filing","n_filings":30,"first_seen":"2024-07-05","last_seen":"2026-08-07"}],"transactions":[{"id":5892998,"accession":"0001104659-26-092838","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-092838","line_url":"/filing/0001104659-26-092838#line-2","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":134.17,"price_display":"134.17","price_state":"stated","total_value":737935.0,"total_display":"737,935.00","total_whole":"737,935","shares_owned_after":168498.0,"shares_owned_after_display":"168,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-05","filed_date":"2026-08-07","scope":"insider"},{"id":5892939,"accession":"0001104659-26-080477","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-080477","line_url":"/filing/0001104659-26-080477#line-2","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":132.74,"price_display":"132.74","price_state":"stated","total_value":730070.0,"total_display":"730,070.00","total_whole":"730,070","shares_owned_after":177873.0,"shares_owned_after_display":"177,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-02","scope":"insider"},{"id":5769524,"accession":"0001104659-26-077427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-077427","line_url":"/filing/0001104659-26-077427#line-1","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26400.0,"shares_display":"26,400","price_per_share":132.6,"price_display":"132.60","price_state":"stated","total_value":3500640.0,"total_display":"3,500,640.00","total_whole":"3,500,640","shares_owned_after":179248.0,"shares_owned_after_display":"179,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-24","scope":"insider"},{"id":6013250,"accession":"0000907654-26-000054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000907654-26-000054","line_url":"/filing/0000907654-26-000054#line-2","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"Oruka Therapeutics, Inc.","issuer_ticker":"ORKA","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12583.0,"shares_display":"12,583","price_per_share":70.109,"price_display":"70.11","price_state":"stated","total_value":882181.547,"total_display":"882,181.55","total_whole":"882,182","shares_owned_after":38743.0,"shares_owned_after_display":"38,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-12","filed_date":"2026-06-12","scope":"insider"},{"id":6013247,"accession":"0000907654-26-000054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000907654-26-000054","line_url":"/filing/0000907654-26-000054#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"Oruka Therapeutics, Inc.","issuer_ticker":"ORKA","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22417.0,"shares_display":"22,417","price_per_share":70.1343,"price_display":"70.13","price_state":"stated","total_value":1572200.6031,"total_display":"1,572,200.60","total_whole":"1,572,201","shares_owned_after":51326.0,"shares_owned_after_display":"51,326","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-11","filed_date":"2026-06-12","scope":"insider"},{"id":5928451,"accession":"0001104659-26-071076","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-071076","line_url":"/filing/0001104659-26-071076#line-2","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":78.71,"price_display":"78.71","price_state":"stated","total_value":432905.0,"total_display":"432,905.00","total_whole":"432,905","shares_owned_after":205648.0,"shares_owned_after_display":"205,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-03","filed_date":"2026-06-05","scope":"insider"},{"id":6190554,"accession":"0000907654-26-000043","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000907654-26-000043","line_url":"/filing/0000907654-26-000043","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"Oruka Therapeutics, Inc.","issuer_ticker":"ORKA","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105000.0,"shares_display":"105,000","price_per_share":58.965393536190476,"price_display":"58.97","price_state":"stated","total_value":6191366.3213,"total_display":"6,191,366.32","total_whole":"6,191,366","shares_owned_after":86978.0,"shares_owned_after_display":"86,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-21","filed_date":"2026-05-22","scope":"insider","n_lines":3},{"id":6132028,"accession":"0001104659-26-058129","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-26-058129","line_url":"/filing/0001104659-26-058129","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":84.14254545454546,"price_display":"84.14","price_state":"stated","total_value":462784.0,"total_display":"462,784.00","total_whole":"462,784","shares_owned_after":208823.0,"shares_owned_after_display":"208,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-06","filed_date":"2026-05-08","scope":"insider","n_lines":2},{"id":5999468,"accession":"0001104659-26-039709","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-26-039709","line_url":"/filing/0001104659-26-039709","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":84.83982545454545,"price_display":"84.84","price_state":"stated","total_value":466619.04,"total_display":"466,619.04","total_whole":"466,619","shares_owned_after":208498.0,"shares_owned_after_display":"208,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-03","scope":"insider","n_lines":3},{"id":6168791,"accession":"0001104659-26-024831","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-26-024831","line_url":"/filing/0001104659-26-024831","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":71.05904545454545,"price_display":"71.06","price_state":"stated","total_value":390824.75,"total_display":"390,824.75","total_whole":"390,825","shares_owned_after":212048.0,"shares_owned_after_display":"212,048","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider","n_lines":3},{"id":5845731,"accession":"0001104659-26-010454","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-26-010454","line_url":"/filing/0001104659-26-010454","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":65.79273272727272,"price_display":"65.79","price_state":"stated","total_value":361860.03,"total_display":"361,860.03","total_whole":"361,860","shares_owned_after":214167.0,"shares_owned_after_display":"214,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-04","filed_date":"2026-02-04","scope":"insider","n_lines":5},{"id":5976067,"accession":"0001104659-26-002574","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-26-002574","line_url":"/filing/0001104659-26-002574","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18700.0,"shares_display":"18,700","price_per_share":77.8402705882353,"price_display":"77.84","price_state":"stated","total_value":1455613.06,"total_display":"1,455,613.06","total_whole":"1,455,613","shares_owned_after":213449.0,"shares_owned_after_display":"213,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-07","filed_date":"2026-01-09","scope":"insider","n_lines":4},{"id":4923409,"accession":"0001104659-25-118986","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-118986","line_url":"/filing/0001104659-25-118986#line-1","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10900.0,"shares_display":"10,900","price_per_share":75.0,"price_display":"75.00","price_state":"stated","total_value":817500.0,"total_display":"817,500.00","total_whole":"817,500","shares_owned_after":271108.0,"shares_owned_after_display":"271,108","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-04","filed_date":"2025-12-05","scope":"insider"},{"id":4800364,"accession":"0001104659-25-108652","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-25-108652","line_url":"/filing/0001104659-25-108652","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10785.0,"shares_display":"10,785","price_per_share":55.06748632359759,"price_display":"55.07","price_state":"stated","total_value":593902.84,"total_display":"593,902.84","total_whole":"593,903","shares_owned_after":282686.0,"shares_owned_after_display":"282,686","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-05","filed_date":"2025-11-07","scope":"insider","n_lines":4},{"id":4112243,"accession":"0001104659-25-096792","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-096792","line_url":"/filing/0001104659-25-096792#line-2","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5110.0,"shares_display":"5,110","price_per_share":39.8,"price_display":"39.80","price_state":"stated","total_value":203378.0,"total_display":"203,378.00","total_whole":"203,378","shares_owned_after":284733.0,"shares_owned_after_display":"284,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-01","filed_date":"2025-10-03","scope":"insider"},{"id":4348450,"accession":"0001104659-25-087939","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-087939","line_url":"/filing/0001104659-25-087939","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2725.0,"shares_display":"2,725","price_per_share":37.870899082568805,"price_display":"37.87","price_state":"stated","total_value":103198.2,"total_display":"103,198.20","total_whole":"103,198","shares_owned_after":233738.0,"shares_owned_after_display":"233,738","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-03","filed_date":"2025-09-05","scope":"insider","n_lines":2},{"id":4548877,"accession":"0001104659-25-075801","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-075801","line_url":"/filing/0001104659-25-075801#line-1","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2725.0,"shares_display":"2,725","price_per_share":37.78,"price_display":"37.78","price_state":"stated","total_value":102950.5,"total_display":"102,950.50","total_whole":"102,951","shares_owned_after":236273.0,"shares_owned_after_display":"236,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-06","filed_date":"2025-08-08","scope":"insider"},{"id":4052147,"accession":"0001104659-25-065888","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-25-065888","line_url":"/filing/0001104659-25-065888","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10090.0,"shares_display":"10,090","price_per_share":45.089597621407336,"price_display":"45.09","price_state":"stated","total_value":454954.04,"total_display":"454,954.04","total_whole":"454,954","shares_owned_after":242679.0,"shares_owned_after_display":"242,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-02","filed_date":"2025-07-03","scope":"insider","n_lines":3},{"id":4548479,"accession":"0001104659-25-057468","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-057468","line_url":"/filing/0001104659-25-057468#line-1","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2725.0,"shares_display":"2,725","price_per_share":36.96,"price_display":"36.96","price_state":"stated","total_value":100716.0,"total_display":"100,716.00","total_whole":"100,716","shares_owned_after":241723.0,"shares_owned_after_display":"241,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-04","filed_date":"2025-06-06","scope":"insider"},{"id":4469256,"accession":"0001104659-25-046896","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-046896","line_url":"/filing/0001104659-25-046896#line-1","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2725.0,"shares_display":"2,725","price_per_share":35.75,"price_display":"35.75","price_state":"stated","total_value":97418.75,"total_display":"97,418.75","total_whole":"97,419","shares_owned_after":244448.0,"shares_owned_after_display":"244,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-07","filed_date":"2025-05-09","scope":"insider"},{"id":5083698,"accession":"0001104659-25-032308","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-032308","line_url":"/filing/0001104659-25-032308","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3860.0,"shares_display":"3,860","price_per_share":36.21794559585492,"price_display":"36.22","price_state":"stated","total_value":139801.27,"total_display":"139,801.27","total_whole":"139,801","shares_owned_after":248562.0,"shares_owned_after_display":"248,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-02","filed_date":"2025-04-04","scope":"insider","n_lines":3},{"id":5206478,"accession":"0001104659-25-021862","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-021862","line_url":"/filing/0001104659-25-021862#line-1","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1590.0,"shares_display":"1,590","price_per_share":30.48,"price_display":"30.48","price_state":"stated","total_value":48463.2,"total_display":"48,463.20","total_whole":"48,463","shares_owned_after":251033.0,"shares_owned_after_display":"251,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"},{"id":5083486,"accession":"0001104659-25-010645","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-010645","line_url":"/filing/0001104659-25-010645#line-2","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3520.0,"shares_display":"3,520","price_per_share":40.69,"price_display":"40.69","price_state":"stated","total_value":143228.8,"total_display":"143,228.80","total_whole":"143,229","shares_owned_after":252623.0,"shares_owned_after_display":"252,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-05","filed_date":"2025-02-07","scope":"insider"},{"id":4198351,"accession":"0001104659-25-000956","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-25-000956","line_url":"/filing/0001104659-25-000956","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4085.0,"shares_display":"4,085","price_per_share":46.93748837209302,"price_display":"46.94","price_state":"stated","total_value":191739.64,"total_display":"191,739.64","total_whole":"191,740","shares_owned_after":255448.0,"shares_owned_after_display":"255,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-03","scope":"insider","n_lines":3},{"id":3201151,"accession":"0001104659-24-128559","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-128559","line_url":"/filing/0001104659-24-128559","is_derivative":false,"issuer_cik":"0001974640","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001974640","owner_cik":"0001983476","owner_name":"Dambkowski Carl","owner_display_name":"Dambkowski Carl","owner_url":"/insider/0001983476","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4540.0,"shares_display":"4,540","price_per_share":48.75830396475771,"price_display":"48.76","price_state":"stated","total_value":221362.7,"total_display":"221,362.70","total_whole":"221,363","shares_owned_after":258528.0,"shares_owned_after_display":"258,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-11","filed_date":"2024-12-13","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2024-12-11|3201149","ledger_fault":false,"count":{"value":62,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":62,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":62},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001974640","name":"Apogee Therapeutics, Inc.","url":"/issuer/0001974640","role":"Officer (Chief Medical Officer)","n_filings":28,"first_seen":"2024-07-05","last_seen":"2026-08-07"},{"type":"issuer","type_label":"ISSUER","cik":"0000907654","name":"Oruka Therapeutics, Inc.","url":"/issuer/0000907654","role":"Director","n_filings":2,"first_seen":"2026-05-22","last_seen":"2026-06-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001983476","retrieved_at":"2026-08-26T06:36:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}